Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3

Journal of Experimental Medicine

Volumn 189, Issue 6, 1999, Pages 895-905

  Valmori, Danila ^a   Gileadi, Uzi ^b   Servis, Catherine ^a   Dunbar, P Rod ^b   Cerottini, Jean Charles ^a   Romero, Pedro ^a   Cerundolo, Vincenzo ^b   Lévy, Frédéric ^a,c  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

Author keywords

Antigen processing; HLA class I molecule; Mass spectrometry; Melanoma cells; Ubiquitin

Indexed keywords

HLA ANTIGEN; LACTACYSTIN; PROTEASOME; TUMOR ANTIGEN;

AMINO TERMINAL SEQUENCE; ANTIGEN PRESENTATION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVITY; HLA SYSTEM; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL;

ACETYLCYSTEINE; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; CYSTEINE ENDOPEPTIDASES; HUMANS; MULTIENZYME COMPLEXES; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; PROTEASOME ENDOPEPTIDASE COMPLEX; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0033559238     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.6.895     Document Type: Article

References (40)

1. Rivett, A.J. 1998. Intracellular distribution of proteasomes. Curr. Opin. Immunol. 10:110-114.
2. Baumeister, W., J. Walz, F. Zühl, and E. Seemüller. 1998. The proteasome: paradigm of a self-compartmentalized protease. Cell. 92:367-380.
3. Coux, O., K. Tanaka, and A.L. Goldberg. 1996. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65:801-847.
4. Ping, M.C., J.H. Vu, R.J. Proske, C.A. Slaughter, and G.N. DeMartino. 1994. Identification, purification and characterization of a high molecular weight, ATP-dependent activator (PA700) of the 20S proteasome. J. Biol. Chem. 269:3539-3547.
5. Ping, M.C., C.A. Slaughter, and G.N. DeMartino. 1992. Identification, purification and characterization of a protein activator (PA28) of the 20S proteasome (macropain). J. Biol. Chem. 267:10515-10523.
6. Dubiel, W., G. Pratt, K. Ferrell, and M. Rechsteiner. 1992. Purification of an 11S regulator of the multicatalytic protease. J. Biol. Chem. 267:22369-22377.
7. Dick, T.P., T. Ruppert, M. Groettrup, P.M. Kloetzel, L. Kuehn, U.H. Koszinowski, S. Stevanovic, H. Schild, and H.-G. Rammensee. 1996. Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell. 86:253-262.
8. Groll, M., L. Ditzel, J. Löwe, D. Stock, M. Bochtler, H.D. Bartunik, and R. Huber. 1997. Structure of 20S proteasome from yeast at 2.4 Å resolution. Nature. 386:463-471.
9. Kopp, F., K.B. Hendil, B. Dahlmann, P. Kristensen, A. Sobek, and W. Uerkvitz. 1997. Subunit arrangement in the human 20S proteasome. Proc. Natl. Acad. Sci. USA. 94:2939-2944.
10. Orlowski, M., C. Cardozo, and C. Michaud. 1993. Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. Biochemistry. 32:1563-1572.
11. Svensson, K., F. Lévy, U. Sundberg, H.-G. Boman, K.B. Hendil, and S. Kvist. 1996. Proteasomes generate in vitro a natural peptide of influenza-A nucleoprotein functional in HLA-B27 antigen assembly. Int. Immunol. 8:467-478.
12. Groettrup, M., A. Soza, U. Kuckelkorn, and P.M. Kloetzel. 1996. Peptide antigen production by the proteasome: complexity provides efficiency. Immunol. Today. 17:429-435.
13. Rock, K.L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A.L. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761-771.
14. Pamer, E., and P. Cresswell. 1998. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16: 323-358.
15. Herman, J., P. van der Bruggen, I.F. Luescher, S. Mandruzzato, P. Romero, J. Thonnard, K. Fleischhauer, T. Boon, and P. Coulie. 1996. A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3. Immunogenetics. 43:377-383.
16. Gaugler, B., B. Van den Eynde, P. van der Bruggen, P. Romero, J.J. Gaforio, E. De Plaen, B. Lethé, F. Brasseur, and T. Boon. 1994. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179:921-930.
17. van der Bruggen, P., J. Bastin, T. Gajewski, P.G. Coulie, P. Boel, C. De Smet, C. Traversari, A. Townsend, and T. Boon. 1994. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol. 24:3038-3043.
18. Valmori, D., D. Liénard, G. Waanders, D. Rimoldi, J.-C. Cerottini, and P. Romero. 1997. Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocytes antigen-A2 melanoma patients. Cancer Res. 57:735-741.
19. Dunbar, P.R., G.S. Ogg, J. Chen, N. Rust, P. van der Bruggen, and V. Cerundolo. 1998. Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood. Curr. Biol. 8:413-416.
20. Lévy, F., N. Johnsson, T. Rümenapf, and A. Varshavsky. 1996. Using ubiquitin to follow the metabolic fate of a protein. Proc. Natl. Acad. Sci. USA. 93:4907-4912.
21. Kocher, T., E. Schultz-Thater, F. Gudat, C. Schaefer, G. Casorati, A. Juretic, T. Willimann, F. Harder, M. Heberer, and G.C. Spagnoli. 1995. Identification and intracellular location of MAGE-3 gene product. Cancer Res. 55:2236-2239.
22. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods. 95:99-105.
23. Hansen, M.B., S.E. Nielsen, and K. Berg. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods. 119:203-210.
24. Ehring, B., T.H. Meyer, C. Eckerskorn, F. Lottspeich, and R. Tampé. 1996. Effects of major-histocompatibility-complex-encoded subunits on the peptidase and proteolytic activities of human 20S proteasomes. Eur. J. Biochem. 235:404-415.
25. DeMars, R., C.C. Chang, S. Shaw, P.J. Reitnauer, and P.M. Sondel. 1984. Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased expression of class II antigens. Human Immunol. 11:77-97.
26. Cerundolo, V., A. Kelly, T. Elliott, J. Trowsdale, and A. Townsend. 1995. Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport. Eur. J. Immunol. 25:554-562.
27. Varshavsky, A. 1997. The ubiquitin system. Trends. Biochem. Sci. 22:383-387.
28. Vinitsky, A., L.C. Anton, H.L. Snyder, M. Orlowski, J.R. Bennink, and J.W. Yewdell. 1997. The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors. J. Immunol. 159:554-564.
29. Fenteany, G., R.F. Standaert, W.S. Lane, S. Choi, E.J. Corey, and S.L. Schreiber. 1995. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science. 268:726-731.
30. Niedermann, G., G. King, S. Butz, U. Birsner, R. Grimm, J. Shabanowitz, D.F. Hunt, and K. Eichmann. 1996. The proteolytic fragments generated by vertebrate proteasomes: structural relationships to major histocompatibility complex class I binding peptides. Proc. Natl. Acad. Sci. USA. 93:8572-8577.
31. Craiu, A., T. Akopian, A. Goldberg, and K.L. Rock. 1997. Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. Proc. Natl. Acad. Sci. USA. 94:10850-10855.
32. Lopez, D., and M. Del Val. 1997. Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation. J. Immunol. 159:5769-5772.
33. Glas, R., M. Bogyo, J.S. McMaster, M. Gaczynka, and H.L. Ploegh. 1998. A proteolytic system that compensates for loss of proteasome function. Nature. 392:618-622.
34. Dick, T.P., A.K. Nussbaum, M. Deeg, W. Heinemeyer, M. Groll, M. Schirle, W. Keilholz, S. Stevanovic, D.H. Wolf, R. Huber, et al. 1998. Contribution of proteasomal β-subunits to the cleavage of peptide substrates analyzed with yeast mutants. J. Biol. Chem. 273:25637-25646.
35. Wilk, S., M. Pereira, and B. Yu. 1991. Probing the specificity of the bovine pituitary multicatalytic proteinase complex by inhibitors, activators, and by chemical modification. Biomed. Biochim. Acta. 50:471-478.
36. Anton, L.C., J.W. Yewdell, and J.R. Bennink. 1997. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. J. Immunol. 158: 2535-2542.
37. Sijts, A.J., A. Neisig, J. Neefjes, and E.G. Pamer. 1996. Two Listeria monocytogenes CTL epitopes are processed from the same antigen with different efficiencies. J. Immunol. 156: 685-692.
38. Anton, L.C., H.L. Snyder, J.R. Bennink, A. Vinitsky, M. Orlowski, A. Porgador, and J.W. Yewdell. 1998. Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides. J. Immunol. 160:4859-4868.
39. Yellen-Shaw, A.J., and L.C. Eisenlohr. 1997. Regulation of class I-restricted epitope processing by local or distal flanking sequence. J. Immunol. 158:1727-1733.
40. André, P., M. Groettrup, P. Klenerman, R. De Giuli, B.L. Booth, V. Cerundolo, M. Bonneville, F. Jotereau, R.M. Zinkernagel, and V. Lotteau. 1998. An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses. Proc. Natl. Acad. Sci. USA. 95:13120-13124.